Friday, March 06, 2026 7:49:47 AM
💥🍿 Mergers and Acquisitions Continue to Happen Quickly. 🤗
CV Sciences next merger/ acquisition announcement coming… 🔮 🤗
https://www.newmediawire.com/news/splash-beverage-group-signs-letter-of-intent-for-acquisition-and-merger-with-established-hemp-and-cbd-operator-medterra-7085696
💥🍿 https://ir.cvsciences.com/press-releases/detail/244/cv-sciences-inc-positioned-to-participate-in-the-medicare
💥🍿
💥🍿 https://ir.cvsciences.com/press-releases/detail/85/cv-sciences-inc-achieves-industrys-first-hemp-extract
💥🍿 https://www.cvsciences.com/
💥🍿 https://elevatedsoftgels.com/
💥 https://tracxn.com/d/companies/elevated-softgels/__NGDUVRYvUpUCjIfEUI7UU30pwMHXJJJnNRNkEb23rbE
💥 https://www.jiabeisupplement.com/softgel-manufacturers-
CV Sciences next merger/ acquisition announcement coming… 🔮 🤗
https://www.newmediawire.com/news/splash-beverage-group-signs-letter-of-intent-for-acquisition-and-merger-with-established-hemp-and-cbd-operator-medterra-7085696
💥🍿 https://ir.cvsciences.com/press-releases/detail/244/cv-sciences-inc-positioned-to-participate-in-the-medicare
💥🍿
Huge thank you to our outstanding speakers for the insightful #CBD Regulatory & Macro Outlook panel today!
— Pablo Zuanic (@420Odysseus) February 11, 2026
Jared Stanley, Co-founder & Board Member, @charlottesweb
Joseph Dowling, CEO, @CV_Sciences
John Harloe, General Counsel, @villagefarms (@theCBDistillery)
Your… pic.twitter.com/rzluB6J7PA
💥🍿 https://ir.cvsciences.com/press-releases/detail/85/cv-sciences-inc-achieves-industrys-first-hemp-extract
💥🍿 https://www.cvsciences.com/
💥🍿 https://elevatedsoftgels.com/
💥 https://tracxn.com/d/companies/elevated-softgels/__NGDUVRYvUpUCjIfEUI7UU30pwMHXJJJnNRNkEb23rbE
💥 https://www.jiabeisupplement.com/softgel-manufacturers-
Bullish
Recent CVSI News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 09:14:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 08:06:03 PM
- CV Sciences, Inc. Reports Fiscal Year-End 2025 Financial Results • ACCESS Newswire • 03/26/2026 08:00:00 PM
- CV Sciences, Inc. To Announce Year End and Fourth Quarter 2025 Results On March 26, 2026 • ACCESS Newswire • 03/24/2026 09:00:00 PM
- CV Sciences Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth • ACCESS Newswire • 03/10/2026 09:00:00 PM
- CV Sciences Launches EMPOWR: A Plant-Based Protein + Creatine Formula Designed for Total Wellness • ACCESS Newswire • 02/26/2026 01:30:00 PM
- CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD • ACCESS Newswire • 12/23/2025 12:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 10:19:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 09:04:08 PM
- CV Sciences, Inc. Reports Third Quarter 2025 Financial Results • ACCESS Newswire • 11/13/2025 09:00:00 PM
- CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025 • ACCESS Newswire • 11/10/2025 11:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2025 09:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:24:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 09:23:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2025 08:01:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2025 08:50:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2025 08:01:33 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/15/2025 09:25:41 PM
